Can CBD Help with My Anxiety and Depression?

Can CBD Help with My Anxiety and Depression?

Boost Search Results
Off

Can CBD Help with My Anxiety and Depression?

Share
No
Marijuana

Cannabidiol, or CBD, is a natural compound that has gained popularity in recent years. Here are some frequently asked questions about CBD answered by two mental health professionals who are working in this area:

1. What exactly is CBD? Is it the same as Cannabis? Hemp? Marijuana plant?

CBD is cannabidiol. It is one of almost 200 cannabinoids that can be found in marijuana plants. Unlike many other cannabinoids, CBD is not psychoactive and has a different pharmacologic profile than other psychoactive cannabinoids. CBD can be extracted from both marijuana plants and from hemp.  

2. Is CBD (and CBD products) safe to use?

If there are adequate safety studies of a product, it would be considered safe. However, the CBD products flooding the market are not likely to have undergone any safety testing. In fact, the FDA has issued several warning letters to firms that market unapproved new drugs that allegedly contain cannabidiol. As part of these actions, the FDA has tested the chemical content of cannabinoid compounds in some of the products, and many were found to not contain the levels of CBD they claimed to contain. It is important to note that these products are not approved by FDA for the diagnosis, cure, mitigation, treatment, or prevention of any disease. Consumers should beware purchasing and using any such products.

3. It seems like CBD is now being used in lots of products (shampoos, cosmetics, oils, bath salts, etc.). Does it really help when it is part of a product?

There is no evidence that CBD has beneficial effects as part of various products. Furthermore, the amount of CBD in any of these products is unclear.

4. Does CBD based medication really help with anxiety and depression and has it been scientifically proven to help with anxiety and depression?

  • There is evidence that CBD may be a useful treatment for a number of medical conditions. However, this research is considerably less advanced than for treatment of epilepsy. For most indications, there is only pre-clinical evidence, while for some there is a combination of pre-clinical and limited clinical evidence. The range of conditions for which CBD has been assessed is diverse, consistent with its neuroprotective, antiepileptic, hypoxia-ischemia, anxiolytic, antipsychotic, analgesic, anti-inflammatory, anti-asthmatic, and antitumor properties.
  • There is insufficient scientific evidence to support the claim that CBD is an effective treatment for depression or anxiety. That does not mean it would not help, but there simply haven’t been properly controlled clinical trials to support an indication of CBD for treating anxiety or depression. Considerably more research is required to evaluate CBD as a potential treatment for anxiety and depression.

5. Is there current research in the US for CBD? Are other countries using CBD?

  • There are dozens of current clinical trials that are evaluating the potential benefits of CBD for a variety of disorders, e.g., alcohol use disorder, pain, anxiety, PTSD, etc. Most of these studies are being conducted in the US, but some are being conducted in other countries. 
  • CBD is also being studied in combination with THC (THC is the main psychoactive compound in Cannabis). The CBD+THC combination product is known as Sativex, which is approved for cancer pain and spasticity in Europe and Asia. 

6. Is CBD FDA approved and can doctors prescribe it?

Purified CBD extract (GW Pharmaceuticals) was approved by the FDA in 2018 as a treatment for 2 rare forms of epilepsy – Dravet syndrome and Lennox-Gastaut syndrome – as a Schedule 5 compound.  The brand name is Epidiolex.  

7. Are there pricing regulations for CBD?

Only for the FDA approved product.

8. How can I be sure that what I am reading about CBD (articles, etc.) is providing truthful information?

Look for scientific evidence to support any claims – controlled trials, evidence that the product under discussion has been assayed by some legitimate source to verify chemical constituents. Engage in a conversation with a medical professional. 

ADAA offers a free online search tool to find mental health professionals from the ADAA member community. Click here to learn more.

The information in this post was graciously provided by Kathleen T. Brady, MD, PhD, Vice President for Research, Medical University of South Carolina, and Christopher D. Verrico, PhD, Assistant Professor, Psychiatry Research, Baylor College of Medicine, Houston, Texas


Additional Resources

The Cannabis That People Are Using for Anxiety Is Probably Making It Worse, The Wall Street Journal, Beth Salcedo, MD 

Download this helpful Myths and Faces About CBD infographic from Consumers for Safe CBD. 

Consumers for Safe CBD.org

Can CBD Reduce Symptoms of Anxiety or Depression? A Research Update, Psycom Pro, Karen Cassiday, PhD

September 2019 Is Cannabis an Effective Treatment for Anxiety - What the Research Shows  Anxiety.org (ADAA member Jeremy Tyler, PsyD quoted)

July 11, 2019  APA Response to FDA Request for Comments on Cannabis Products

July 16, 2019. Public Comments Submission Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds.  In response to the US Food and Drug Administration's (FDA) request for comments dated April 3, 2019. 

Trending Articles/Press Releases

ADAA Blog Content and Blog Comments Policy

ADAA Blog Content and Blog Comments Policy

ADAA provides this Website blogs for the benefit of its members and the public. The content, view and opinions published in Blogs written by our personnel or contributors – or from links or posts on the Website from other sources - belong solely to their respective authors and do not necessarily reflect the views of ADAA, its members, management or employees. Any comments or opinions expressed are those of their respective contributors only. Please remember that the open and real-time nature of the comments posted to these venues makes it is impossible for ADAA to confirm the validity of any content posted, and though we reserve the right to review and edit or delete any such comment, we do not guarantee that we will monitor or review it. As such, we are not responsible for any messages posted or the consequences of following any advice offered within such posts. If you find any posts in these posts/comments to be offensive, inaccurate or objectionable, please contact us via email at [email protected] and reference the relevant content. If we determine that removal of a post or posts is necessary, we will make reasonable efforts to do so in a timely manner.

ADAA expressly disclaims responsibility for and liabilities resulting from, any information or communications from and between users of ADAA’s blog post commenting features. Users acknowledge and agree that they may be individually liable for anything they communicate using ADAA’s blogs, including but not limited to defamatory, discriminatory, false or unauthorized information. Users are cautioned that they are responsible for complying with the requirements of applicable copyright and trademark laws and regulations. By submitting a response, comment or content, you agree that such submission is non-confidential for all purposes. Any submission to this Website will be deemed and remain the property of ADAA.

The ADAA blogs are forums for individuals to share their opinions, experiences and thoughts related to mental illness. ADAA wants to ensure the integrity of this service and therefore, use of this service is limited to participants who agree to adhere to the following guidelines:

1. Refrain from transmitting any message, information, data, or text that is unlawful, threatening, abusive, harassing, defamatory, vulgar, obscene, that may be invasive of another 's privacy, hateful, or bashing communications - especially those aimed at gender, race, color, sexual orientation, national origin, religious views or disability.

Please note that there is a review process whereby all comments posted to blog posts and webinars are reviewed by ADAA staff to determine appropriateness before comments are posted. ADAA reserves the right to remove or edit a post containing offensive material as defined by ADAA.

ADAA reserves the right to remove or edit posts that contain explicit, obscene, offensive, or vulgar language. Similarly, posts that contain any graphic files will be removed immediately upon notice.

2. Refrain from posting or transmitting any unsolicited, promotional materials, "junk mail," "spam," "chain mail," "pyramid schemes" or any other form of solicitation. ADAA reserves the right to delete these posts immediately upon notice.

3. ADAA invites and encourages a healthy exchange of opinions. If you disagree with a participant 's post or opinion and wish to challenge it, do so with respect. The real objective of the ADAA blog post commenting function is to promote discussion and understanding, not to convince others that your opinion is "right." Name calling, insults, and personal attacks are not appropriate and will not be tolerated. ADAA will remove these posts immediately upon notice.

4. ADAA promotes privacy and encourages participants to keep personal information such as address and telephone number from being posted. Similarly, do not ask for personal information from other participants. Any comments that ask for telephone, address, e-mail, surveys and research studies will not be approved for posting.

5. Participants should be aware that the opinions, beliefs and statements on blog posts do not necessarily represent the opinions and beliefs of ADAA. Participants also agree that ADAA is not to be held liable for any loss or injury caused, in whole or in part, by sponsorship of blog post commenting. Participants also agree that ADAA reserves the right to report any suspicions of harm to self or others as evidenced by participant posts.

RESOURCES AND NEWS
Evidence-based Tips & Strategies from our Member Experts
RELATED ARTICLES
Block reference